LBF20406AM27: Difference between revisions
No edit summary |
No edit summary |
||
(16 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{Lipid/Header}} | |||
{{Hierarchy|{{PAGENAME}}}} | {{Hierarchy|{{PAGENAME}}}} | ||
Line 4: | Line 6: | ||
|LipidBank=XPR7043 | |LipidBank=XPR7043 | ||
|LipidMaps=LMFA08020029 | |LipidMaps=LMFA08020029 | ||
|SysName=N- | |SysName=N-Hydroxy-N- (cis-5,cis-8,cis-11,cis-14) -eicosatetraenoylamine | ||
|Melting Point=colorless oil | |Common Name=&&N-Hydroxy-N-arachidonoylamide&&N-Hydroxy-N- (5Z,8Z,11Z,14Z) -eicosatetraenoylamine&& | ||
|NMR Spectra= | |Melting Point=colorless oil [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]] | ||
|NMR Spectra=^1 H NMR (CDCl3) delta 5.30-5.43 (m, 8H), 2.78-2.86 (m, 6H), 2.02-2.17 (m, 6H), l.70-1.78(m, 2H), 1.22-1.38 (m, 6H), 0.89 (t, J=6.9 Hz, 3H). [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]] | |||
|Source= | |||
|Chemical Synthesis=This compound was synthesized from arachidonoyl chloride and hydroxylamine hydrochloride.Yield 49%. [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]] | |||
|Metabolism= | |||
|Biological Activity=Binding to the brain cannabinoid receptor (CBl), Ki (nM)>1000 [[Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659|{{RelationTable/GetFirstAuthor|Reference:Sheskin_T:Hanus_L:Slager_J:Vogel_Z:Mechoulam_R:,J. Med. Chem.,1997,40,659}}]] | |||
}} | }} | ||
{{Lipid/Footer}} |
Latest revision as of 04:46, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR7043 |
LipidMaps | LMFA08020029 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20406AM27 |
N-Hydroxy-N-arachidonoylamide | |
---|---|
Structural Information | |
N-Hydroxy-N- (cis-5,cis-8,cis-11,cis-14) -eicosatetraenoylamine | |
| |
Formula | C20H33NO2 |
Exact Mass | 319.251129305 |
Average Mass | 319.48156 |
SMILES | C(CC=CCC=CCC=CCC=CCCCC(NO)=O)CCC |
Physicochemical Information | |
colorless oil Sheskin_T et al. | |
This compound was synthesized from arachidonoyl chloride and hydroxylamine hydrochloride.Yield 49%. Sheskin_T et al. | |
Binding to the brain cannabinoid receptor (CBl), Ki (nM)>1000 Sheskin_T et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | 1H NMR (CDCl3) δ 5.30-5.43 (m, 8H), 2.78-2.86 (m, 6H), 2.02-2.17 (m, 6H), l.70-1.78(m, 2H), 1.22-1.38 (m, 6H), 0.89 (t, J=6.9 Hz, 3H). SheskinTet al. |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|